News
PRECISESADS, a European project to search for new treatments for systemic autoimmune diseases
The project has more than 22 million euros of funding for the next 5 years Systemic autoimmune diseases (SAD) PRECISESADS Molecular map
Described the evolution of a family of proteins key to life
Article’s reference The Vertebrate RCAN Gene Family: Novel Insights into Evolution, Structure and Regulation
Confirmed the role of genes POLD1 and POLE in hereditary colorectal cancer and in cases of colonic polyposis
The journal of Human Molecular Genetics publishes this week a study led by Laura Valle and Ignacio Blanco, with the collaborations of other members of the Hereditary Cancer Program of the ICO IDIBELL and researchers from Valencia. The article provides new evidence on the role of mutations in genes POLD1 POLE and in cases of […]
Fundación Sandra Ibarra and Philips fund a research project about nutrition and breast cancer of ICO-IDIBELL
On February 13 took place the event for awarding the Philips Grant for Research in Nutrition and Breast Cancer of Fundación Sandra Ibarra at the headquarters of the Catalan Institute of Oncology (ICO) at L’Hospitalet de Llobregat. The project awarded with the grant is entitled “Biomarkers of diet and metabolic risk in patients with breast […]
Researchers associate telomere length with risk of developing cancer in hereditary colorectal cancer
PLoS ONE publishes this week a study led by researcher Laura Valle, Hereditary Cancer Program ICO- IDIBELL, which shows that presence of longer telomeres is associated with increased risk of developing cancer in hereditary colorectal cancer without identified genetic cause. The study involved several members of the Hereditary Cancer Program and Biomarkers and Susceptibility Unit […]
WORLD CANCER DAY: The most common tumors in women are breast, colorectal and corpus uteri and in men, prostate, lung and colorectal
February 4th is World Day against Cancer. In Catalonia, this disease is the most common cause of death in men and the second in women. The World Health Organization dedicates the day, like last year, to break myths about the disease. You can view the most common myths by clicking here. During 2013 the Catalan […]
Researchers discover an epigenetic mark that could be useful for classifying leukemic origin and disease relapse
An international study between the Imprinting and Cancer Group within the Cancer Epigenetics and Biology Program (PEBC) and the Institute of Human Genetics, at Christian-Albrechts University, Kiel, Germany, describe a methylation signature that is a promising marker for classifying myeloid-derived leukemias. Gene Wilms tumor 1 (WT1) is over-expressed in numerous cancers with respect to normal […]